Campaign launched to rally Multiple Sclerosis patients in potential class action lawsuit against the manufacturer of pharmaceutical drugs Tysabri and Avonex.

Eli Lilly and Co. will pay $690 million to settle approximately three-quarters of the claims against Zyprexa. The Brown and Crouppen law firm has developed a press release that explains the Zyprexa situation and the importance of filing claims promptly.